🔎 Trials Near Me

Hem › Blåscancer › Pennsylvania

Kliniska studier för Blåscancer i Pennsylvania

27 studier för Blåscancer söker deltagare vid platser i Pennsylvania.

Städer i Pennsylvania

Officiell studietext (engelska)

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

  • Geisinger Medical Center, Danville
  • Geisinger Cancer Center Dickson City, Dickson City
  • Geisinger Medical Oncology-Lewisburg, Lewisburg
  • och 3 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT07000084

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • Geisinger Medical Center, Danville
  • och 7 fler
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

  • Christiana Care Health System-Concord Health Center, Chadds Ford
  • Geisinger Medical Center, Danville
  • Geisinger Cancer Center Dickson City, Dickson City
  • och 17 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT06770582

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

  • MidLantic Urology ( Site 0102), Bala-Cynwyd
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT06833073

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
  • Asplundh Cancer Pavilion, Willow Grove
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT07061964

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • Pocono Medical Center, East Stroudsburg
  • och 8 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT03866382

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07277413

DESTINY-PANTUMOUR04

  • Research Site, Philadelphia
RekryterarObservationsstudie
Ålder 18 till 130 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07124000

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  • Lancaster General Hospital - Ann B Barshinger Cancer Institute, Lancaster
  • AHN Allegheny General Hospital, Pittsburgh
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07218380

Prehabilitation in High-risk Oncologic Surgery

  • Fox Chase Cancer Center - Philadelphia, Philadelphia
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 21 sep. 2026 · NCT07638410

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT07217171

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • University of Pennsylvania, Philadelphia
  • WellSpan Medical Oncology & Hematology at York Cancer Center, York
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT05059444

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

  • Midlantic Urology (Solaris), Bala-Cynwyd
  • Penn State University Milton S. Hershey Medical Center, Hershey
  • Keystone Urology Specialists, Lancaster
  • och 1 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT06567743

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

  • University of Pittsburgh Medical Center, Pittsburgh
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 24 aug. 2026 · NCT05951179

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

  • Penn Medicine Lancaster General Hospital - Ann B. Barshinger Cancer Institute, Lancaster
  • University of Pennsylvania, Philadelphia
  • Thomas Jefferson University, Philadelphia
  • och 2 fler
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 20 aug. 2026 · NCT05614739

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

  • Christiana Care Health System-Concord Health Center, Chadds Ford
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 18 aug. 2026 · NCT07097142

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 7 aug. 2026 · NCT04752722

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Thomas Jefferson University, Philadelphia
RekryterarFas 2
Ålder 8 och äldre · Alla kön · Uppdaterad 27 juli 2026 · NCT05503797

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

  • Penn State Medical Center, Urology Research, Hershey
Rekryterar
Ålder 18 till 88 · Alla kön · Uppdaterad 2 juli 2026 · NCT06394869

Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer

  • University of Pennsylvania, Philadelphia
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 14 maj 2026 · NCT06586255

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

  • Abramson Cancer Center, Philadelphia
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 13 maj 2026 · NCT07048496

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

  • Allegheny Health Network, Pittsburgh
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 5 mars 2026 · NCT04075305

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

  • University of Pennsylvania, Philadelphia
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 18 feb. 2026 · NCT07030257

Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy

  • Thomas Jefferson University Hospital, Philadelphia
  • Jefferson Einstein Philadelphia Hospital, Philadelphia
Rekryterar
Ålder 18 till 85 · Alla kön · Uppdaterad 17 feb. 2026 · NCT07234968

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 13 feb. 2026 · NCT06778863

Virtual Histology of the Bladder Wall for Bladder Cancer Staging

  • UPMC Hillman Cancer Center - Dept of Urology, Pittsburgh
RekryterarTidig fas 1
Ålder 18 till 90 · Alla kön · Uppdaterad 17 dec. 2025 · NCT04369560

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Philadelphia
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.